NEW YORK – October 28, 2026 -- Andel, a direct-to-employer medication marketplace, has agreed a collaboration with Novo to offer Wegovy, including the once-daily Wegovy pill and Wegovy HD, to its employer network. Both products launched earlier in 2026.

Barcelona – October 06, 2026 -- Veeva Systems (NYSE: VEEV) said its Data Quality System (DQS) has aggregated and cleaned data for more than 1 million subjects across over 1,000 clinical studies, automating over 500,000 queries and eliminating thousands of hours of manual data reconciliation for sites and sponsors.

New York – September 30, 2026 -- Direct-to-patient healthcare company Ro presented the first real-world evidence on Novo Nordisk's oral Wegovy pill at the EASD2026 meeting in Milan on September 30, based on outcomes from patients on its platform who switched from an injectable GLP-1.